Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Breast Neoplasms 25Lung Neoplasms 24Colonic Neoplasms 18Head and Neck Neoplasms 16Rectal Neoplasms 14Sarcoma 10Prostatic Neoplasms 10Neoplasm Metastasis 9Pancreatic Neoplasms 8Neoplasms 7Mouth Neoplasms 7Melanoma 7Esophageal Neoplasms 7Ovarian Neoplasms 6Glioblastoma 6Adenomatous Polyposis Coli 6Precancerous Conditions 5Neuroblastoma 5Liver Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4

Interventions

Secretin 2Everolimus 2Sirolimus 1Celecoxib 1CA-19-9 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Peutz-Jeghers Syndrome × Celecoxib × Clear all
NCT06722534 2025-05-30

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome

Air Force Military Medical University, China

Phase NA Recruiting
80 enrolled

Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡